DNA amplifications and elevated expression of proto-oncogene in addition to altered DNA ploidy in metastatic brain tumors

Clin Exp Metastasis. 1994 Jul;12(4):267-75. doi: 10.1007/BF01753833.

Abstract

The histopathological characteristics, proto-oncogene amplification, immunohistopathology of the c-erbB-2 product distribution, and the DNA content of nuclei were examined in metastatic brain tumors, which consisted of seven adenocarcinomas, a large cell carcinoma, a squamous cell carcinoma, a renal cell carcinoma and a mucoepidermoid carcinoma. A very high incidence of DNA changes was seen in these tumors. Proto-oncogene amplification and abnormal DNA content in the nuclear portion were found in 64% (7/11) and 67% (6/9) of cases, respectively. We also found double oncogene alteration in three cases metastasizing from lung, esophagus and kidney, and triple oncogene alteration in one case metastasizing from breast. We could not identify the common alterations in the group of metastatic brain tumor cells. These data suggest that the proto-oncogene amplifications and the alteration of DNA ploidy pattern may contribute to the metastatic process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms / genetics*
  • DNA, Neoplasm / genetics*
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism
  • Fibroblast Growth Factor 3
  • Fibroblast Growth Factors / genetics
  • Gene Amplification
  • Genes, myc
  • Humans
  • Neoplasm Metastasis
  • Ploidies
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-yes
  • Proto-Oncogenes*
  • Receptor, ErbB-2
  • src-Family Kinases*

Substances

  • DNA, Neoplasm
  • FGF3 protein, human
  • Fibroblast Growth Factor 3
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Fibroblast Growth Factors
  • ErbB Receptors
  • Receptor, ErbB-2
  • Proto-Oncogene Proteins c-yes
  • src-Family Kinases